Zobrazeno 1 - 10
of 71
pro vyhledávání: '"David O. Prichard"'
Autor:
Juan Reyes Genere, MD, Hee Eun Lee, MD, PhD, Tsung-Teh Wu, MD, David O. Prichard, MB, BCh, PhD, Kenneth K. Wang, MD
Publikováno v:
VideoGIE, Vol 4, Iss 8, Pp 361-363 (2019)
Externí odkaz:
https://doaj.org/article/c56687c687094994b055cccfb322dd26
Recent advances in understanding and managing chronic constipation [version 1; referees: 2 approved]
Autor:
David O. Prichard, Adil E. Bharucha
Publikováno v:
F1000Research, Vol 7 (2018)
Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (f
Externí odkaz:
https://doaj.org/article/7bbdede67287427e888d6b74b0f94442
Publikováno v:
Digestive Diseases and Sciences. 68:750-760
Autor:
David O. Prichard, Jeffrey Fetzer
Publikováno v:
Digestive Diseases and Sciences. 68:922-930
Retained Food During Esophagogastroduodenoscopy Is a Risk Factor for Gastric-to-Pulmonary Aspiration
Autor:
Aoife M. Feighery, Nicholas R. Oblizajek, Matthew N. P. Vogt, Danse Bi, John League, Navtej S. Buttar, David O. Prichard
Publikováno v:
Digestive Diseases and Sciences. 68:164-172
Autor:
David O. Prichard, Lawrence Szarka
Publikováno v:
Yamada's Textbook of Gastroenterology. :1093-1121
Publikováno v:
Digestive Diseases and Sciences. 67:3036-3044
Lower urinary tract symptoms (LUTS) are frequently reported by constipated patients. Prospective studies investigating the association between defecatory disorders (DDs) and voiding dysfunction, predominantly in women, have reported conflicting resul
Publikováno v:
Gastroenterology. 161:e1-e3
Publikováno v:
Digestive Diseases and Sciences. 66:3951-3959
Retained gastric food (RGF) identified during esophagogastroduodenoscopy (EGD) is often attributed to gastroparesis. This retrospective study evaluated the prevalence of RGF, risk factors for RGF, and the association between RGF and delayed gastric e
Autor:
David O. Prichard, Eduardo A. Rodriguez, Sara Then, Kelli N. Burger, Douglas W. Mahoney, Kari L. Lowrie, Allon Kahn, Lila J. Finney, Jamie Bering, Jason D. Eckmann, David A. Ahlquist, John B. Kisiel, Karen A. Doering, Derek Ebner, Mary E. Devens, Paul J. Limburg, Barry M. Berger, Michael B. Wallace, Suryakanth R. Gurudu
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: Multitarget stool DNA (MT-sDNA) testing has grown as a noninvasive screening modality for colorectal cancer (CRC), but real-world clinical data are limited in the post-FDA approval setting. The effect of previous colonoscopy on MT-sDNA pe